Strumento inattivo

Azioni Amylin Pharmaceuticals LLC

Azioni

Prezzo di chiusura Nasdaq Altri mercati azionari
- ^USD	-

Amylin Pharmaceuticals, Inc. : Bristol-Myers Squibb and AstraZeneca Complete Expansion of Diabetes Alliance Through Bristol-Myers Squibb's Acquisition of Amylin	09/08/12
Bristol Myers Squibb Co. : Bristol-Myers executive charged with insider trading	02/08/12
BioMarin Pharmaceutical Inc. : GSK clinches deal to buy Human Genome for $3 billion	16/07/12
GlaxoSmithKline plc : Exclusive: GSK set for Human Genome takeover - sources	16/07/12
GlaxoSmithKline plc : GSK in weekend talks to buy Human Genome: sources	15/07/12

Settore

	Variaz. 1 gen.	Capi.
CSL LIMITED	+0,46%	91,38 Mrd
SAMSUNG BIOLOGICS CO.,LTD.	-2,37%	38,68 Mrd
UCB	+72,37%	27,84 Mrd
BIOMARIN PHARMACEUTICAL INC.	-12,31%	16,05 Mrd
INCYTE CORPORATION	-4,54%	13,48 Mrd
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-10,83%	11,73 Mrd
ALTEOGEN INC.	+180,20%	10,74 Mrd
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-48,60%	10,39 Mrd
SWEDISH ORPHAN BIOVITRUM AB	+1,95%	8,94 Mrd